VAT1 抗体 (AA 421-525) (FITC)
Quick Overview for VAT1 抗体 (AA 421-525) (FITC) (ABIN719823)
抗原
See all VAT1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 421-525
-
交叉反应
- 小鼠, 大鼠
-
预测反应
- Human,Dog,Cow,Pig,Horse,Chicken
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human VMAT1
-
亚型
- IgG
-
-
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- VAT1 (Vesicle Amine Transport 1 (VAT1))
-
别名
- VAT1
-
背景
-
Synonyms: Adrenal chromaffin granule amine transporter, CGAT, CGAT, Chromaffin granule amine transporter, SLC18A1, Solute carrier family 18 vesicular monoamine, member 1, Solute carrier family 18 member 1, VAT 1, VAT1, Vesicular amine transporter 1, VMAT 1, VMAT1, VMAT1_HUMAN.
Background: The vesicular monoamine transporter acts to accumulate cytosolic monoamines into vesicles, using the proton gradient maintained across the vesicular membrane. Its proper function is essential to the correct activity of the monoaminergic systems that have been implicated in several human neuropsychiatric disorders. The transporter is a site of action of important drugs, including reserpine and tetrabenazine (Peter et al., 1993 [PubMed 7905859]). See also SLC18A2 (MIM 193001).[supplied by OMIM, Mar 2008].
-
分子量
- 56kDa
-
基因ID
- 6570
-
UniProt
- P54219
抗原
-